Early Breast Cancer: When to Consider Skipping Chemotherapy

Join Dr. Francisco Javier Esteva, a renowned medical oncologist from New York City, as he delves into the critical role of chemotherapy for patients with early-stage breast cancer. In today’s comprehensive episode, Dr. Esteva navigates through the complexities of breast cancer treatment, exploring whether chemotherapy can be avoided in selected patients with hormone receptor positive, HER2-negative early-stage breast cancer.
#cancer #breastcancer #breastcancerawareness
About:
Cancer Treatment Updates is a deep-dive podcast focusing on cancer biology, research and treatment. It features topics including molecular classification of cancer and its impact on prognosis, predictive markers, chemotherapy, endocrine therapy, targeted therapy, immunotherapy, surgery, radiation therapy, risk assessment, survivorship and much more.
Dr. Francisco Javier Esteva is a medical oncologist based in New York City. He currently serves as Chief of Hematology and Medical Oncology at Lenox Hill Hospital, an academic institution of Northwell Health. Opinions are his own, and not reflective of the opinions or views of his employer.
Learn more: www.cancertreatmentupdates.com
Follow Dr. Esteva:
Instagram / dresteva
Facebook www.facebook.c...
Twitter (X) / cancerrxupdates
TikTok / dresteva
LinkedIn / franciscoesteva
Google Scholar: scholar.google...
RUclips / @cancertreatmentupdates
Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this visual podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. Please review our Terms of Use: www.cancertrea....

[@LCDC5759]

Thank you so much for this video Dr.Esteva, this is very informative

[@cancertreatmentupdates]

You are very welcome

[@stormwalker321]

thank you so much, very good information, Much gratitude to you for your kindness in sharing it...🙏

[@vilimainamoqolaki7101]

No chemo for me because my troke. Taking Texoxifen though. Got biopsy done again another breast

[@jimrandall9927]

Does this channel know about Dr Thomas Seyfried s work ?

[@cancertreatmentupdates]

You are so welcome

[@dinkaman2160pukka]

thank u for the informative updates. Cn you please do the Triple Negative BC at stage 1A and no lymph node involvement? Thank you so much.

[@jackieg5307]

Thanks for the video, I just wish you would have gave info on Triple Negative.

[@cancertreatmentupdates]

Thank you for your comment. The main topic was when to avoid chemotherapy in ER/PR+ and HER2- breast cancer. I’ll cover triple negative breast cancer in future video podcasts.

[@diegodejesusmondragon4895]

I am a 64 year old male with stage 2 male breast cancer. Positive Estrogen receptor 5% and positive Progesterone receptor 40%. If I have low risk lymph glands score of 25 or lower would I need chemotherapy?

[@dagmarvandoren9364]

Recht herzlichen dank...

[@cancertreatmentupdates]

You’re welcome! Glad you liked the video.

[@JannyMouse]

Mine was 27 but I was post-menopausal so I didn’t have to have it.

[@cancertreatmentupdates]

I am glad you didn’t have to take chemotherapy. We are learning how best to optimize multi-gene tests to understand who is likely to benefit from chemotherapy. In general terms, chemotherapy is used when the Oncotype Recurrence Score is greater than 25, but each case is different. This video is for educational purposes only, and none of the information provided should be considered medical advice.